Skip to main content

November 2025

Crack GPAT — Prepare for GPAT Online 

Research Fellow Opening at Public Health Foundation of India | Annual CTC will be up to 6 lakh per year

Masters Degree in Microbiology, Molecular Biology, Epidemiology, Public Health, Health Security or a related field within the life sciences. 
Apply Online for Operations Director at BIRAC
Director Operations is a Member of the Board of Directors and reports to the Managing Director. He / She is overall in-charge of matters related to promoting and nurturing innovation research and growth with reference to BIRACs mandate and empower and enable the biotech innovation eco system
Interview for M.Pharm, B.Pharm, MSc in Production, QA, QC, Packing at Emcure
Emcure is fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally.
Openings for M.Pharm, B.Pharm, MSc in Production, QA, QC at Biovonic Healthcare
Preparation and Review of warehouse SOPs and Documentations. Candidate should have good control on written english.
Multiple opportunities in Quality & Regulatory Departments at Gloss Pharmaceutical
For a competitive compensation package aligned with industry benchmarks, along with a performance-based growth structure and opportunities for career advancement.
Amgen looking for Quality Compliance Manager
GCP Subject Matter Expert, Provide independent and objective quality advice in support of clinical trial activities and in line with current standard methodology. Experience in Quality Management, Quality Assurance. pharmaceuticals
Walk in Drive for M.Pharm, B.Pharm, MSc in Production, QA, QC at BioMatrix Healthcare
B.Pharm, M.Pharm, M.Sc. work in QA Department, Production Department, QC department. BioMatrix Healthcare
Sanofi Require Senior Biostatistician
Master or PhD of pharmaceutical. Perform statistical analyses of data from the laboratories using R and possibly other languages SAS or standard statistical software used in Sanofi, JMP, SIMCA, internal tools. Sanofi
Repatha lowers risk of first major heart events by 25% in Amgen’s Phase 3 VESALIUS-CV trial
Amgen announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in major adverse cardiovascular events (MACE) in high-risk adults without a prior heart attack or stroke
Novo Nordisk India collaborates with Emcure Pharma to commercialise Poviztra® as the second brand of Wegovy® in India
Novo Nordisk India and Emcure Pharma announced a strategic partnership to launch Poviztra, semaglutide injection 2.4 mg, in India.